Clinical value of CT-guided percutaneous fine-needle aspiration biopsy for peritoneal lesions

Hualong Yu, Chuanyu Zhang, Shihe Liu, Gang Jiang, Shaoke Li, Liang Zhang, Yongjie Wang, Wenjian XuBMC Medical Imaging 2020 · DOI

TL;DR

This study investigates the clinical utility of CT-guided percutaneous fine-needle aspiration biopsy (CT-PFNA) for diagnosing peritoneal lesions of unknown origin. The findings demonstrate that CT-PFNA is a safe and highly accurate method, achieving a 95.1% accuracy rate, making it a valuable tool for identifying the cause of peritoneal thickening and guiding treatment.

What Problem Does This Paper Address?

Peritoneal lesions, characterized by thickening of the peritoneum, can arise from various causes, including malignancies and inflammatory conditions. Differentiating between these causes is crucial for effective treatment, but conventional clinical and radiological examinations often lack the specificity needed for a definitive diagnosis. While ultrasound-guided biopsy and laparoscopy are established methods for obtaining tissue samples, they have limitations. Ultrasound can be hindered by intestinal gas and has a narrower scope, while laparoscopy is invasive, costly, and carries higher risks. This paper addresses the need for a safe, accurate, and accessible method for diagnosing peritoneal lesions, exploring the role of CT-guided percutaneous fine-needle aspiration biopsy (CT-PFNA) in this context.

Methods

The study employed a retrospective analysis of 84 patients who underwent CT-guided percutaneous fine-needle aspiration biopsy for peritoneal lesions between January 2012 and December 2015. Patients were selected based on peritoneal thickening of unknown cause. The procedure involved using a Philips Brilliance 16-slice CT scanner with specific parameters (120 kV, 150 mA, 3 mm slice thickness, 1.375 pitch). Local anesthesia with 2% lidocaine was administered. Patients were trained to control their breathing during the procedure. A guide wire grid was used for initial localization, and the puncture site was carefully chosen to avoid major blood vessels and the intestinal canal. For lesions close to the intestinal canal, a coaxial needle was employed. Typically, 3-6 specimens were collected per patient. Post-biopsy, patients were monitored for complications, and follow-up examinations were conducted at 3, 6, and 12 months to assess diagnostic consistency and accuracy.

Datasets

The study utilized data from 84 patients who underwent CT-guided percutaneous fine-needle aspiration biopsy at the authors' hospital. No external datasets were used for training or evaluation. The "dataset" in this context refers to the retrospective collection of patient cases and their associated clinical and pathological information.

Key Insights and Ideas

  • CT-PFNA as a Viable Alternative: The study strongly supports CT-PFNA as a safe and effective alternative to more invasive diagnostic procedures for peritoneal lesions.
  • High Diagnostic Accuracy: The remarkable 95.1% accuracy rate highlights the reliability of CT-PFNA in achieving a correct pathological diagnosis.
  • Distinguishing Malignancy from Benign Causes: The method proved adept at differentiating between malignant conditions (like peritoneal metastases and mesothelioma) and benign causes (such as tuberculosis and inflammatory lesions), which is critical for treatment planning.
  • Minimizing Complications: While complications can occur, the study's low incidence (13.1%) and the management of serious events like bleeding suggest that with proper technique, CT-PFNA can be performed with acceptable safety.
  • Addressing Diagnostic Challenges: The paper underscores the difficulty in diagnosing peritoneal lesions based solely on imaging and highlights how CT-PFNA overcomes these limitations by providing direct tissue samples.

Key Results

  • Accuracy: The overall accuracy rate of CT-guided percutaneous fine-needle aspiration biopsy was 95.1% (77 out of 81 patients with follow-up data).
  • Malignant Diagnoses: 74.1% (60 lesions) were diagnosed as malignancies, including 55 with peritoneal metastases, 4 with malignant mesotheliomas, and 1 with lymphoma.
  • Benign Diagnoses: 33.8% (24 patients) were diagnosed with benign lesions, comprising 11 with tuberculous peritonitis and 13 with inflammatory lesions.
  • Complications: A total of 11 out of 84 patients (13.1%) experienced complications. The most serious was bleeding in one patient (1.2%), which was managed conservatively. Other mild complications included pain and abdominal wall edema.
  • False Negative Rate: The false negative rate was 4.9% (4/81).
  • False Positive Rate: The false positive rate was 0%.

Limitations and Future Work

The authors acknowledge several limitations:

  • Treatment Scheme Bias: The study population was skewed towards patients with peritoneal metastases, as the treatment scheme was often based on pathological results, potentially limiting the generalizability to benign lesions.
  • Lost to Follow-up: Three patients were lost to follow-up, preventing a definitive diagnosis for these cases.
  • Radiation Exposure: CT guidance was primarily used when ultrasound was insufficient, implying a conscious effort to minimize radiation exposure, which might have led to a smaller sample size for CT-guided procedures.

Future work could focus on:

  • Expanding the study to include a larger and more diverse patient population, particularly those with benign peritoneal lesions.
  • Investigating techniques to further minimize complications, such as optimizing needle trajectory and sampling speed.
  • Comparing the cost-effectiveness and diagnostic yield of CT-PFNA against other minimally invasive biopsy techniques in a prospective setting.

Summary updated

BibTeX
@article{yu2020clinical,
  author = {Hualong Yu and Chuanyu Zhang and Shihe Liu and Gang Jiang and Shaoke Li and Liang Zhang and Yongjie Wang and Wenjian Xu},
  title = {{Clinical value of CT-guided percutaneous fine-needle aspiration biopsy for peritoneal lesions}},
  journal = {BMC Medical Imaging},
  year = {2020},
  doi = {10.1186/s12880-020-00512-0},
}
Figure